Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
3.
Med Mycol ; 52(3): 303-10, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24577007

RESUMO

Paracoccidioidomycosis (PCM) is a systemic mycosis endemic to Latin America. Brazil accounts for approximately 80% of cases, where it represents a major public health issue due to its disabling impact and the number of premature deaths it causes. We present a retrospective cohort study that was conducted in order to better understand factors that relate to cure of the infection in the treatment of 200 patients with PCM. We evaluated the influence of sociodemographic and clinical factors as well as therapeutic regimen (trimethoprim-sulfamethoxazole [TMP-SMX] and itraconazole) on the progress of PCM (cure and noncure). There was a higher incidence of cure (83%) among patients who regularly received treatment for their infections and completed the treatment protocol. Moreover, itraconazole (86.4%) was significantly superior to TMP-SMX (51.3%) in terms of cure rate and had a median treatment period that was significantly shorter (12 months) than that for TMP-SMX (23 months). A Cox proportional hazard regression model showed that use of itraconazole increased the hazard of cure, regardless of sex, age, education, clinical form, completion of treatment, and regularity. Although the results of this study show that itraconazole was the best treatment option for PCM patients, a double-blind, randomized, controlled trial is necessary to confirm this conclusion.


Assuntos
Antifúngicos/uso terapêutico , Itraconazol/uso terapêutico , Paracoccidioidomicose/tratamento farmacológico , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Brasil , Estudos de Coortes , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento , Adulto Jovem
4.
J Clin Monit Comput ; 28(6): 525-36, 2014 12.
Artigo em Inglês | MEDLINE | ID: mdl-24072471

RESUMO

In the last decades propofol became established as an intravenous agent for the induction and maintenance of both sedation and general anesthesia procedures. In order to achieve the desired clinical effects appropriate infusion rate strategies must be designed. Moreover, it is important to avoid or minimize associated side effects namely adverse cardiorespiratory effects and delayed recovery. Nowadays, to attain these purposes the continuous propofol delivery is usually performed through target-controlled infusion (TCI) systems whose algorithms rely on pharmacokinetic and pharmacodynamic models. This work presents statistical models to estimate both the infusion rate and the bolus administration. The modeling strategy relies on multivariate linear models, based on patient characteristics such as age, height, weight and gender along with the desired target concentration. A clinical database collected with a RugLoopII device on 84 patients undergoing ultrasonographic endoscopy under sedation-analgesia with propofol and remifentanil is used to estimate the models (training set with 74 cases) and assess their performance (test set with 10 cases). The results obtained in the test set comprising a broad range of characteristics are satisfactory since the models are able to predict bolus, infusion rates and the effect-site concentrations comparable to those of TCI. Furthermore, comparisons of the effect-site concentrations for dosages predicted by the proposed Linear model and the Marsh model for the same target concentration is achieved using Schnider model and a factorial design on the factors (patients characteristics). The results indicate that the Linear model predicts a dosage profile that is faster in leading to an effect-site concentration closer to the desired target concentration.


Assuntos
Anestésicos/administração & dosagem , Monitoramento de Medicamentos/métodos , Quimioterapia Assistida por Computador/métodos , Modelos Lineares , Propofol/administração & dosagem , Propofol/farmacocinética , Anestésicos Intravenosos/administração & dosagem , Anestésicos Intravenosos/sangue , Anestésicos Intravenosos/farmacocinética , Simulação por Computador , Humanos , Infusões Intravenosas , Análise Multivariada , Modelagem Computacional Específica para o Paciente , Propofol/sangue
5.
Fisioter. Bras ; 4(5): f353-359, set.-out. 2003. ilus
Artigo em Português | LILACS | ID: lil-352186

RESUMO

A interaçao dos idosos em asilos,casas de repouso e similares está sendo questionada ate nos paises desenvolvidos,onde estes serviços alcançaram nivel altamente sofisticados em termos de conforto e eficiencia. O custo desse modelo e as dificuldades de sua manutençao estao requerendo medidas resolutivas e menos onerosas. O retorno ao modelo de cuidados familiares, ja bastante discutido, nao pode ter como unica finalidade baratear custos ou transferir responsabilidades. A assistencia domiciliar fisioterapeutica aos idosos, cuja capacidade funcional esta comprometida, demanda programas de orientaçao, informaçao e assessoria de especialistas.


Assuntos
Instituição de Longa Permanência para Idosos , Relações Familiares
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...